EBS
Emergent Biosolutions Inc
6.30$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +73.3% | -29.0% | +49.7% | +56.5% | +16.9% | +19.8% | -2.4% | +31.5% | +21.9% | -4.5% | +3.1% | +10.9% | +29.3% | +21.0% | -0.1% | +14.8% | +39.5% | +41.4% | +42.6% | +12.4% | -37.0% | -6.1% | -0.5% | -28.8% | |
| – | -94.2% | – | – | +5.0% | -23.7% | +67.1% | -15.5% | +35.7% | +1.8% | -10.5% | +301.5% | +7.5% | +13.5% | +4.9% | +12.5% | +13.6% | +66.6% | +34.8% | +14.7% | +37.3% | -34.3% | +7.0% | -3.1% | -41.3% | |
| – | – | +3.3% | -4.3% | +85.6% | +29.8% | +10.9% | +1.3% | +30.5% | +26.8% | -3.3% | -51.3% | +16.1% | +51.3% | +37.8% | -10.2% | +15.8% | +13.0% | +50.8% | +78.7% | -8.1% | -40.4% | -23.9% | +4.3% | -6.6% | |
| – | -98.5% | – | – | +81.7% | +147.5% | +18.6% | +10.2% | +25.4% | +19.7% | +39.8% | +4.0% | -7.6% | -12.7% | +13.8% | -10.3% | -8.9% | +46.6% | +58.4% | +5.2% | -1.1% | -19.9% | -40.8% | -36.5% | -23.9% | |
| – | – | – | – | +51.3% | +47.3% | -38.3% | -0.9% | +34.0% | +3.3% | -2.5% | +2.3% | +15.6% | +39.8% | +20.9% | -3.2% | -0.1% | +41.1% | +35.1% | +10.9% | +14.6% | -2.1% | +9.6% | -17.4% | -39.6% | |
| – | -98.1% | – | – | +26.5% | +76.1% | +21.5% | +4.6% | +29.5% | +11.5% | +20.3% | -59.5% | +9.0% | +23.6% | +20.6% | +6.4% | +14.4% | +44.8% | +60.0% | +15.1% | +6.4% | +42.3% | +69.0% | -55.4% | -50.3% | |
| – | – | +47.7% | -69.9% | +27.2% | +78.2% | -13.0% | -9.6% | +34.2% | +83.2% | -56.4% | +13.9% | +17.1% | +108.4% | +58.7% | -25.4% | +17.8% | -27.8% | +27.1% | +284.3% | -22.1% | -149.8% | – | – | – | |
| – | -100.0% | – | – | – | – | -90.7% | -33.8% | -85.1% | -100.0% | – | – | -100.0% | – | -20.8% | +16.8% | -13.5% | +50.2% | +287.9% | -18.5% | +10.2% | +8.1% | +135.7% | -19.2% | -16.5% | |
| – | – | – | – | +27.2% | +80.1% | -5.3% | -9.0% | +26.8% | +76.7% | -56.5% | +0.4% | +35.2% | +94.1% | +61.2% | -26.9% | +19.6% | -31.3% | -5.0% | +432.2% | -26.4% | -172.2% | – | – | – | |
| – | -65.1% | -707.6% | – | +3.8% | +185.9% | -14.3% | -7.6% | +24.1% | +74.9% | -39.5% | -12.1% | -5.8% | +128.3% | +48.0% | -17.2% | -1.9% | -47.8% | +21.8% | +363.3% | -21.1% | -108.8% | – | +62.8% | -36.7% | |
| – | – | -87.8% | +157.6% | +37.6% | +44.4% | +0.6% | -9.8% | +50.6% | +66.0% | -55.5% | +2.2% | +32.4% | +18.0% | +71.1% | -17.6% | +59.5% | -24.1% | -13.1% | +461.1% | -28.2% | -196.4% | – | – | – | |
| – | -16.6% | +47.7% | -66.5% | +35.9% | +72.6% | -13.6% | -2.3% | +25.6% | +70.6% | -48.0% | +15.6% | +36.2% | +87.0% | +53.5% | -28.8% | +31.5% | -11.2% | +66.9% | +135.3% | -17.2% | -96.9% | -399.4% | – | +350.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.